← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

M 10b5-1 Plan

$ Value

$0

Shares

83,978

Price

$0

Filed

Nov 14

Insider

Name

Randhawa Simrat

Title

EVP, Head of R&D

CIK

0001992260

Roles

Officer

Transaction Details

Transaction Date

2025-11-13

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

11,996

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.48 to $36.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.48 to $37.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.48 to $38.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001992260-25-000008

Form Type

4

Issuer CIK

0001690585

Randhawa Simrat's History

Date Ticker Type Value
2026-03-12 DNTH M $68K
2026-03-12 DNTH M $89K
2026-03-12 DNTH M $181K
2026-03-12 DNTH M $276K
2026-03-12 DNTH $2.8M
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0
2026-02-03 DNTH A $0

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.6M 2026-03-12
Garcia Marino
CEO AND PRESIDENT
$10.0M 2026-03-12
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
$2.8M 2026-03-12
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09